Equities

Shanghai Rightongene Biotechnology Co Ltd

688217:SHH

Shanghai Rightongene Biotechnology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)21.58
  • Today's Change0.42 / 1.98%
  • Shares traded2.43m
  • 1 Year change-44.74%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments230294324
Total Receivables, Net200263177
Total Inventory615437
Prepaid expenses151318
Other current assets, total3.80----
Total current assets510624556
Property, plant & equipment, net368317235
Goodwill, net253346
Intangibles, net504046
Long term investments725757
Note receivable - long term------
Other long term assets------
Total assets1,0441,084948
LIABILITIES
Accounts payable145111
Accrued expenses182213
Notes payable/short-term debt1.512.860
Current portion long-term debt/capital leases5.822.974.70
Other current liabilities, total3.20114.16
Total current liabilities439033
Total long term debt228.103.96
Total debt29148.65
Deferred income tax6.818.165.52
Minority interest22357.85
Other liabilities, total5.076.097.95
Total liabilities9814759
SHAREHOLDERS EQUITY
Common stock565656
Additional paid-in capital736725718
Retained earnings (accumulated deficit)154156116
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity946937889
Total liabilities & shareholders' equity1,0441,084948
Total common shares outstanding565656
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.